Imperative Care has announced a new organisational structure designed to accelerate the company’s growth across its businesses. As per an Imperative press release, this new business architecture connects a “continuum of stroke and vascular care” for patients, from onset through post-acute care.
Co-founded in 2016 by serial entrepreneur Fred Khosravi and neuroendovascular surgery pioneer L Nelson ‘Nick’ Hopkins, Imperative was set up with a singular focus on transforming stroke care from detection through recovery and making better treatment available to more patients, according to the release.
This focus has since expanded to develop treatments for other ischaemic diseases, such as pulmonary embolism and peripheral vascular disease.
Imperative is now also the parent company of four businesses that share a common purpose to bring more care to more people affected by stroke and other ischaemic diseases, including:
- Imperative Care Stroke—a business unit focused on bringing interventional treatments to patients with ischaemic and haemorrhagic stroke
- Imperative Care Vascular (formerly TRUVIC Medical, acquired by Imperative Care in 2021)—a business unit advancing innovative treatments for people suffering from vascular diseases like pulmonary embolism
- Kandu Health—a digital health company aiming to change the course of stroke recovery and post-acute care through remote support
- Telos Health—a business unit using robotics and automation to optimise vascular intervention with the goal of making stroke and vascular thrombectomies accessible to more people
“Our vision for Imperative Care has always been to bring forward clinically meaningful innovations that are inspired and shaped by physicians and unmet clinical needs impacting patient care,” said Khosravi, current chairman and CEO of Imperative. “We believe that the patient is the only constant in the chain of care from detection through treatment and recovery. Through connected innovation, we can look holistically at what the patient needs across the full continuum of care and achieve something meaningful for patients and their families.”
“The advent of thrombectomy over the last few decades has brought one of the most powerful treatments in medicine to patients,” said Imperative co-founder Hopkins, who is also founder and chief scientific officer of the Jacobs Institute in Buffalo, USA. “But this incredible success has also resulted in a fragmented approach to acute stroke, with many companies focused on different approaches to clot removal. From its inception, Imperative Care has taken a unique approach from detection all the way through to treatment and post-acute care, with a focus on enabling a better recovery for survivors—holistically focusing on the patient rather than the disease alone.”
“Through our businesses and development programmes, we are building a portfolio of connected innovations that tangibly elevate care for patients, resulting in durable growth into the back half of this decade, and for decades to come,” said Matthew Garrett, chief financial officer at Imperative. “Every day, this purpose-built company is one step closer to making this vision a reality.”
